Advertisement
Advertisement
U.S. markets close in 1 hour 57 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Shenzhou International Group Holdings Limited (2313.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
83.700-0.350 (-0.42%)
At close: 04:08PM HKT
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close84.050
Open84.500
Bid83.650 x 0
Ask83.700 x 0
Day's Range83.550 - 85.950
52 Week Range76.700 - 191.000
Volume3,456,708
Avg. Volume5,279,991
Market Cap125.82B
Beta (5Y Monthly)0.91
PE Ratio (TTM)32.19
EPS (TTM)2.600
Earnings DateAug 25, 2022
Forward Dividend & Yield1.14 (1.44%)
Ex-Dividend DateJun 06, 2022
1y Target Est135.02
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for 2313.HK

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • GlobeNewswire

      LifeMD Provides Initial FY2022 Guidance and Announces Preliminary FY2021 Revenues

      Total FY2022 revenue anticipated to be in the range of $142 to $148 million Remains on track to achieve Adjusted EBITDA profitability by Q4 2022 Reports preliminary fourth quarter revenue of $27.4 million and FY2021 consolidated revenue of $92.9 million, +149% vs. year-ago period NEW YORK, Jan. 19, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD) today announced initial FY2022 revenue guidance of $142 to $148 million and reaffirmed previous guidance of achieving Adjusted EBIT

    • GlobeNewswire

      LifeMD to Participate in the Upcoming Virtual BTIG Conference

      NEW YORK, Jan. 18, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (the “Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that management will participate in the virtual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 15-17, 2022. To request a one-on-one meeting with management, please register here. About LifeMDLifeMD, Inc. is a rapidly growing direct-to-patient telehealth company that offers cash-pay virtual medical care acros

    • GlobeNewswire

      LifeMD Announces Key Appointments to Drive Launch of Proprietary Virtual Care Platform

      Appointments add key technology and direct-to-consumer marketing expertise for the rollout of LifeMD’s virtual primary care platform.NEW YORK, Jan. 04, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced the appointments of Dennis Wijnker as Chief Technology Officer and Garett Hunter as Senior Vice President and General Manager of LifeMD Primary Care. Wijnker succeeds Stefan Galluppi, who will continue in his role as LifeMD’s Chie

    Advertisement
    Advertisement